Annual report
6062.TEDINET S100P9KJ
Period2021-07-01 → 2022-06-30
Filed2022-09-29
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 23 passed
Amended by S100Q38N (2023-02-06). Amended by S100UFYN (2024-09-27).
Key figures · 127
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥29.1bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥23.0bn | 2020-07-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥2.3bn | 2021-07-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥2.0bn | 2020-07-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.5bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.3bn | 2020-07-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥4.5bn | 2021-07-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.3bn | 2020-07-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.0bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2020-07-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.0bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥1.5bn | 2020-07-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥37.4bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥28.6bn | at 2021-06-30 | Cons. | Assets |
| Total liabilities | ¥24.9bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥17.5bn | at 2021-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥12.5bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥11.1bn | at 2021-06-30 | Cons. | Net assets |
| Net assets / equity | ¥9.8bn | at 2020-06-30d | Cons. | Net assets |
| Cash and deposits | ¥6.9bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.9bn | at 2021-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.9bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.9bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2020-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.9bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.6bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.9bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.7bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥88m | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.5bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥90.5 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.09 | 2020-07-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥90.33 | 2021-07-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥47.01 | 2020-07-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥380.44 | at 2022-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥339.66 | at 2021-06-30 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 33.2% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.7% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 25.1% | 2021-07-01 → 2022-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.9% | 2020-07-01 → 2021-06-30 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,965 | at 2022-06-30 | Cons. | Number of employees |
| Employees | 1,550 | at 2021-06-30 | Cons. | Number of employees |
| Revenue | ¥27.0bn | 2021-07-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥22.0bn | 2020-07-01 → 2021-06-30 | Standalone | Net sales |
| Revenue | ¥19.6bn | 2019-07-01 → 2020-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.6bn | 2018-07-01 → 2019-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥13.6bn | 2017-07-01 → 2018-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.4bn | 2021-07-01 → 2022-06-30 | Standalone | Operating income |
| Operating income | ¥2.0bn | 2020-07-01 → 2021-06-30 | Standalone | Operating income |
| Ordinary income | ¥2.6bn | 2021-07-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥2.4bn | 2020-07-01 → 2021-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥1.8bn | 2019-07-01 → 2020-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2018-07-01 → 2019-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥995m | 2017-07-01 → 2018-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.4bn | 2021-07-01 → 2022-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥2.3bn | 2020-07-01 → 2021-06-30 | Standalone | Income before income taxes |
| Net income | ¥2.3bn | 2021-07-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | ¥1.6bn | 2020-07-01 → 2021-06-30 | Standalone | Profit loss |
| Net income | ¥1.2bn | 2019-07-01 → 2020-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.0bn | 2018-07-01 → 2019-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥616m | 2017-07-01 → 2018-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥35.6bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥28.5bn | at 2021-06-30 | Standalone | Assets |
| Total assets | ¥24.0bn | at 2020-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.8bn | at 2019-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥17.2bn | at 2018-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥23.7bn | at 2022-06-30 | Standalone | Liabilities |
| Total liabilities | ¥17.2bn | at 2021-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥11.9bn | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥11.2bn | at 2021-06-30 | Standalone | Net assets |
| Net assets / equity | ¥9.8bn | at 2020-06-30d | Standalone | Net assets |
| Net assets / equity | ¥4.6bn | at 2019-06-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.7bn | at 2018-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.2bn | at 2022-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.7bn | at 2021-06-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥5.6bn | at 2020-06-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.2bn | at 2019-06-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.4bn | at 2018-06-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.2bn | 2019-07-01 → 2020-06-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2018-07-01 → 2019-06-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.3bn | 2017-07-01 → 2018-06-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.2bn | 2019-07-01 → 2020-06-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2018-07-01 → 2019-06-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.3bn | 2017-07-01 → 2018-06-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥3.3bn | 2019-07-01 → 2020-06-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥594m | 2018-07-01 → 2019-06-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.5bn | 2017-07-01 → 2018-06-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥70.01 | 2021-07-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥49.01 | 2020-07-01 → 2021-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.4 | 2019-07-01 → 2020-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.96 | 2018-07-01 → 2019-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.04 | 2017-07-01 → 2018-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥69.88 | 2021-07-01 → 2022-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥48.93 | 2020-07-01 → 2021-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥39.35 | 2019-07-01 → 2020-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥35.93 | 2018-07-01 → 2019-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥23.04 | 2017-07-01 → 2018-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥17 | 2021-07-01 → 2022-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥12 | 2020-07-01 → 2021-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥6.5 | 2019-07-01 → 2020-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2018-07-01 → 2019-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2017-07-01 → 2018-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥362.46 | at 2022-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥342.67 | at 2021-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥300.12 | at 2020-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥162.94 | at 2019-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥132.55 | at 2018-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 33.2% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.3% | at 2021-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.8% | at 2020-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.3% | at 2019-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.6% | at 2018-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 19.9% | 2021-07-01 → 2022-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.2% | 2020-07-01 → 2021-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.8% | 2019-07-01 → 2020-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 24.4% | 2018-07-01 → 2019-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.0% | 2017-07-01 → 2018-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 32,712,000 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 32,712,000 | at 2021-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 32,712,000 | at 2020-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,056,000 | at 2019-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,056,000 | at 2018-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,695 | at 2022-06-30 | Standalone | Number of employees |
| Employees | 1,512 | at 2021-06-30 | Standalone | Number of employees |
| Employees | 1,336 | at 2020-06-30d | Standalone | Number of employees |
| Employees | 1,152 | at 2019-06-30d | Standalone | Number of employees |
| Employees | 1,009 | at 2018-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 57
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2021-07-01 → 2022-06-30 | ¥1m |
| Otherother segments | depreciation | 2021-07-01 → 2022-06-30 | ¥3m |
| Otherother segments | employees | at 2022-06-30 | 52 pure |
| Otherother segments | revenue | 2021-07-01 → 2022-06-30 | ¥4.2bn |
| Otherother segments | revenue external | 2021-07-01 → 2022-06-30 | ¥4.0bn |
| Otherother segments | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥237m |
| Otherother segments | segment assets | at 2022-06-30 | ¥581m |
| Otherother segments | segment profit | 2021-07-01 → 2022-06-30 | ¥653m |
| Reconciling Itemsreconciling | depreciation | 2021-07-01 → 2022-06-30 | ¥14m |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2022-06-30 | −¥237m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2022-06-30 | −¥237m |
| Reconciling Itemsreconciling | segment assets | at 2022-06-30 | ¥7.0bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-06-30 | −¥846m |
| Nursing Carereportable segment | capex | 2021-07-01 → 2022-06-30 | ¥2.7bn |
| Nursing Carereportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥588m |
| Nursing Carereportable segment | employees | at 2022-06-30 | 1871 pure |
| Nursing Carereportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥25.1bn |
| Nursing Carereportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥25.1bn |
| Nursing Carereportable segment | segment assets | at 2022-06-30 | ¥29.8bn |
| Nursing Carereportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥2.5bn |
| —segment total | capex | 2021-07-01 → 2022-06-30 | ¥2.7bn |
| —segment total | depreciation | 2021-07-01 → 2022-06-30 | ¥591m |
| —segment total | employees | at 2022-06-30 | 1923 pure |
| —segment total | revenue | 2021-07-01 → 2022-06-30 | ¥29.3bn |
| —segment total | revenue external | 2021-07-01 → 2022-06-30 | ¥29.1bn |
| —segment total | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥237m |
| —segment total | segment assets | at 2022-06-30 | ¥30.4bn |
| —segment total | segment profit | 2021-07-01 → 2022-06-30 | ¥3.2bn |
| Otherother segments | capex | 2020-07-01 → 2021-06-30 | ¥494m |
| Otherother segments | depreciation | 2020-07-01 → 2021-06-30 | ¥4m |
| Otherother segments | revenue | 2020-07-01 → 2021-06-30 | ¥1.1bn |
| Otherother segments | revenue external | 2020-07-01 → 2021-06-30 | ¥1.0bn |
| Otherother segments | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥106m |
| Otherother segments | segment assets | at 2021-06-30 | ¥858m |
| Otherother segments | segment profit | 2020-07-01 → 2021-06-30 | ¥7m |
| Reconciling Itemsreconciling | capex | 2020-07-01 → 2021-06-30 | ¥18m |
| Reconciling Itemsreconciling | depreciation | 2020-07-01 → 2021-06-30 | ¥12m |
| Reconciling Itemsreconciling | revenue | 2020-07-01 → 2021-06-30 | −¥106m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-07-01 → 2021-06-30 | −¥106m |
| Reconciling Itemsreconciling | segment assets | at 2021-06-30 | ¥7.1bn |
| Reconciling Itemsreconciling | segment profit | 2020-07-01 → 2021-06-30 | −¥813m |
| Nursing Carereportable segment | capex | 2020-07-01 → 2021-06-30 | ¥2.5bn |
| Nursing Carereportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥460m |
| Nursing Carereportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥22.0bn |
| Nursing Carereportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥22.0bn |
| Nursing Carereportable segment | segment assets | at 2021-06-30 | ¥20.6bn |
| Nursing Carereportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥2.8bn |
| —segment total | capex | 2020-07-01 → 2021-06-30 | ¥3.0bn |
| —segment total | depreciation | 2020-07-01 → 2021-06-30 | ¥464m |
| —segment total | revenue | 2020-07-01 → 2021-06-30 | ¥23.1bn |
| —segment total | revenue external | 2020-07-01 → 2021-06-30 | ¥23.0bn |
| —segment total | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥106m |
| —segment total | segment assets | at 2021-06-30 | ¥21.5bn |
| —segment total | segment profit | 2020-07-01 → 2021-06-30 | ¥2.8bn |
| Otherother segments | employees | at 2022-06-30 | 7 pure |
| Nursing Carereportable segment | employees | at 2022-06-30 | 1646 pure |
| —segment total | employees | at 2022-06-30 | 1653 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,399
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | Prior2YearInstant | － | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 28597605000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 37355446000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | － | |
| Net assets per share (5-year summary) | Prior3YearInstant | － | |
| Net assets per share (5-year summary) | Prior2YearInstant | － | |
| Net assets per share (5-year summary) | Prior1YearInstant | 339.66 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 380.44 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | － | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | － | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | － | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 47.09 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 90.50 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 47.01 | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | 90.33 | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | － | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | － | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | － | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.387 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.332 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | － | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | － | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | － | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.139 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.251 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 25.8 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 10.6 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | － | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | － | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | － | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 2558781000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 3945925000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | － | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | － | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | － | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -3704763000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -2857180000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | － | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | － | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | － | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 1472785000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -87915000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | － | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 23 of 23 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |